山東威高集團醫用高分子製品股份有限公司（股票代码：01066，公告日期：2026年5月13日）于当日于香港联交所场内回购普通股240,000股，占当日前已发行股本约0.0054%。本次回购价格介乎每股3.47港元至3.50港元，总金额836,200港元（约83.62万港元）。
本次回购完成后，公司已发行股本变更为4,467,203,524股，库存股数增至55,128,800股。公司回购授权的决议于2025年5月27日获得通过，授权总数为451,560,392股，目前已合计回购48,480,400股，占授权通过当日已发行股本约10.7362%。根据相关规则要求，本次回购后30天内公司将暂止新股发行或处置库存股，暂止期截至2026年6月13日。
公司确认已遵守香港联交所上市规则及相关法例，公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.